Electroconvulsive Therapy: The Misunderstood Treatment That Still Works

The Treatment Stigma Nearly Killed

Electroconvulsive therapy (ECT) has a response rate between 70% and 90% for severe major depression, making it the single most effective acute treatment available for the condition. By comparison, antidepressant medications achieve remission in roughly 30-40% of patients on their first trial. Yet ECT remains one of the most stigmatized treatments in modern medicine, its reputation shaped more by Hollywood portrayals and historical abuses than by its clinical track record. Approximately 100,000 Americans receive ECT each year, a fraction of those who might benefit.

The gap between ECT's efficacy and its public perception represents one of psychiatry's most consequential disconnects. Understanding the treatment requires separating its painful history from its modern practice, which bears little resemblance to the procedures depicted in films like "One Flew Over the Cuckoo's Nest."

From 1938 to the Present

Italian neurologists Ugo Cerletti and Lucio Bini administered the first ECT treatment to a human patient in Rome in April 1938. Cerletti had observed that pigs given electric shocks before slaughter became docile and hypothesized that electrically induced seizures might treat psychiatric conditions, building on earlier convulsive therapy using chemical agents.

Early ECT was administered without anesthesia or muscle relaxants. Patients were awake. Their bodies convulsed violently. Bone fractures were common. The procedure was genuinely traumatic. It was also used coercively in psychiatric institutions, applied to patients who had not consented and for conditions it was never meant to treat.

How Modern ECT Works

A modern ECT session looks nothing like its historical predecessor. The patient arrives at a treatment suite, typically in a hospital outpatient setting. An anesthesiologist administers a short-acting general anesthetic (usually methohexital or propofol) and a muscle relaxant (succinylcholine). The patient is unconscious within seconds and feels nothing during the procedure.

Electrodes are placed on the scalp in one of several configurations. The ECT device delivers a precisely controlled electrical stimulus — measured in millicoulombs — that induces a generalized seizure lasting approximately 25 to 60 seconds. The seizure is monitored via electroencephalogram (EEG). The patient's body shows minimal movement due to the muscle relaxant. The entire procedure takes about 10 minutes. Patients typically recover consciousness within 15-30 minutes.

• Acute treatment courses usually involve 6-12 sessions administered 2-3 times per week
• Right unilateral electrode placement reduces cognitive side effects compared to bilateral placement
• Ultra-brief pulse width (0.3 milliseconds vs. 1.0 millisecond) further reduces memory effects while maintaining efficacy
• Maintenance ECT — sessions at gradually increasing intervals — can prevent relapse in patients who responded to acute treatment

Why ECT Works: Theories and Evidence

Despite over 80 years of use, the precise mechanism by which ECT relieves depression is not fully understood. The seizure itself appears to be the therapeutic element, not the electricity. Several leading hypotheses exist, none mutually exclusive.

Neuroimaging studies show that ECT increases the volume of the hippocampus — a brain region that shrinks in chronic depression. ECT also alters the functional connectivity between brain regions, normalizing patterns disrupted in depression. It increases levels of brain-derived neurotrophic factor (BDNF), a protein involved in neuronal growth and survival. Neurotransmitter systems including serotonin, dopamine, and gamma-aminobutyric acid (GABA) are all affected.

Conditions ECT Treats

While depression is the primary indication, ECT is effective for several other conditions. It remains the fastest-acting treatment for acute suicidality and catatonia, where delays can be life-threatening.

Side Effects and Risks

The most significant side effect of ECT is memory disruption. Patients commonly experience confusion immediately after treatment (postictal confusion), which resolves within an hour. Retrograde amnesia — difficulty recalling events from weeks or months before treatment — occurs in a significant minority of patients. Some report persistent memory gaps, though studies disagree on the frequency and severity of long-term effects.

• Short-term memory impairment during the treatment course is common and usually resolves within weeks of the final session
• Right unilateral ultra-brief pulse ECT produces significantly fewer memory side effects than bilateral brief-pulse ECT
• Headache, muscle soreness, and nausea occur in some patients after individual sessions
• Mortality risk is approximately 1 in 50,000 treatments, comparable to the risk of general anesthesia for minor surgical procedures

Informed Consent and Ethical Considerations

The coercive use of ECT in the mid-20th century left deep ethical scars. Modern practice requires informed consent. Patients must be told about the procedure, its risks, its benefits, and alternative treatments before agreeing to ECT. In most jurisdictions, ECT cannot be administered involuntarily except through court order and only after a finding that the patient lacks capacity to consent and that ECT is medically necessary.

Some patient advocacy groups continue to oppose ECT. Their concerns — about cognitive effects, about the history of misuse, about whether consent can be truly informed during a severe depressive episode — are legitimate and warrant ongoing scrutiny. The American Psychiatric Association, the National Institute of Mental Health, and the Royal College of Psychiatrists all endorse ECT as a safe and effective treatment when appropriately indicated and properly administered.

An Effective Tool That Demands Respect

ECT occupies an unusual position in medicine: a treatment with strong evidence of efficacy that many patients and clinicians avoid due to stigma. For individuals with severe, treatment-resistant depression — people who have tried multiple medications, psychotherapy, and other interventions without relief — ECT can be transformative. It is not a cure. Relapse rates without continuation treatment are high. But for those in the depths of an illness that carries a 15% lifetime mortality rate from suicide, ECT offers something that few other treatments can match: rapid, reliable relief.

This article is for informational purposes only. Consult a qualified professional.